====== Eliana Castillo ======

{{ ::castillo_2020.jpeg?150|}}

Dr. **Eliana Castillo** is a Canadian immunologist and [[infectious diseases]] specialist based in Calgary, Alberta.

===== Career and Affiliations =====

==== University of British Columbia ====

Castillo completed a fellowship as a clinical assistant professor at the [[University of British Columbia]] (UBC).((//Live Q&A: COVID-19 vaccine.// (2021, September 29). Calgary Health Foundation. https://www.calgaryhealthfoundation.ca/events/live-qa-covid-19-vaccine/))

==== University of Calgary ====

Castillo is a clinical associate professor in the Department of Microbiology Immunology and Infectious Diseases at the [[University of Calgary]].((//Eliana Castillo.// (2020, July 29). Cumming School of Medicine. https://archive.ph/m1R96))

==== Public Health Agency of Canada ====

Castillo is a liaison representative for the [[Society of Obstetrics and Gyneacologists]] on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))

==== Canadian Immunization Research Network ====

Castillo is a co-investigator for the Social Sciences and Humanities Network (SSHN) at the [[Canadian Immunization Research Network]].((//Social Sciences and Humanities Network (SSHN).// (2014, October 22). CIRN | Canadian Immunization Research Network. https://cirnetwork.ca/network/social-sciences-and-humanities-network/))
===== Presentations =====

Castillo was a workshop facilitator for a presentation on [[pertussis vaccines]] at the 2016 [[Canadian Immunization Conference]], sponsored by [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Innovative Medicines Canada]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[Public Health Ontario]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Seqirus]], [[Vaccines 411]] and [[pharmaceutical_companies:Valneva]].((//CIC 2016 Final Program.// Canadian Immunization Conference. Retrieved April 22, 2022, from https://web.archive.org/web/20220420010352/https://www.cpha.ca/sites/default/files/uploads/conferences/2021/cic16-final-program-en.pdf))